SIGNATURE THERAPEUTICS

Serial Number 85510329
606

Registration Progress

Application Filed
Jan 6, 2012
Under Examination
Feb 5, 2013
Approved for Publication
Dec 11, 2012
Published for Opposition
Dec 11, 2012
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SIGNATURE THERAPEUTICS
Previous Owner: Signature Therapeutics, Inc.
Classes: 005, 042

Trademark Image

SIGNATURE THERAPEUTICS

Basic Information

Serial Number
85510329
Filing Date
January 6, 2012
Published for Opposition
December 11, 2012
Abandonment Date
March 7, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 7, 2016
Classes
005 042

Rights Holder

Signature Therapeutics, Inc.

03
Address
1731 Embarcadero Road, Suite 220
Palo Alto, CA 94303

Ownership History

Signature Therapeutics, Inc.

Original Applicant
03
San Carlos, CA

Signature Therapeutics, Inc.

Owner at Publication
03
Palo Alto, CA

Legal Representation

Attorney
Hoang-chi Truong

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

44 events
Date Code Type Description Documents
Mar 7, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Mar 7, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 7, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 6, 2015 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 30, 2015 EXT5 S SOU EXTENSION 5 FILED Loading...
Jul 30, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 27, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 26, 2015 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 21, 2015 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 21, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 24, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 23, 2014 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 21, 2014 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 21, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 8, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 7, 2014 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 28, 2014 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 28, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 13, 2013 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 4, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 3, 2013 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 1, 2013 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 30, 2013 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 1, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 5, 2013 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 11, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 11, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 21, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 7, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 7, 2012 ALIE A ASSIGNED TO LIE Loading...
Oct 23, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 23, 2012 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Oct 23, 2012 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Oct 23, 2012 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Oct 23, 2012 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 2, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 2, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 2, 2012 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 12, 2012 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 12, 2012 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 12, 2012 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 12, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 11, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 10, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the modulation of GABA receptors; pharmaceutical preparations for anesthesia and anesthetic purposes for surgical and non-surgical use; pharmaceutical preparations for sedation and sedative purposes for surgical and non-surgical use; pharmaceutical preparations for antiemesis and antiemetic purposes for surgical and non-surgical use; pharmaceutical preparations for the prevention, treatment, and management of pain, addiction withdrawal, anxiety, insomnia, migraines, nausea, vomiting, neurodegenerative conditions of the nervous system, seizures, trauma to the central nervous system, free radical-associated diseases and disorders, attention deficit hyperactivity disorder, chronic fatigue syndrome, brain injury, narcolepsy, and obesity; pharmaceutical preparations, namely, prodrugs used to deliver drugs in a manner that provides a modified PK profile, tamper resistance, abuse resistance, and overdose protection
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Research and development in the pharmaceutical and biotechnology fields; consulting services in the field of pharmaceutical and biotechnology research and development
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"